Large deletions in BRCA1 have previously been shown to be associated with an increased risk of breast cancer risk (OR = 1.42) compared with carriers of BRCA1 pathogenic single nucleotide variants or Indels50. The gene discussed is BRCA1; the disease is breast carcinoma.